Expanding Insights: Harnessing Expansion Microscopy for Super-Resolution Analysis of HIV-1-Cell Interactions.

HIV-1 HIV-1 capsid HIV-1 nuclear import HIV-1 post-entry expansion microscopy super-resolution microscopy ultrastructure expansion microscopy virus–host interaction

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
15 Oct 2024
Historique:
received: 28 08 2024
revised: 07 10 2024
accepted: 09 10 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 26 10 2024
Statut: epublish

Résumé

Expansion microscopy has recently emerged as an alternative technique for achieving high-resolution imaging of biological structures. Improvements in resolution are achieved by physically expanding samples through embedding in a swellable hydrogel before microscopy. However, expansion microscopy has been rarely used in the field of virology. Here, we evaluate and characterize the ultrastructure expansion microscopy (U-ExM) protocol, which facilitates approximately four-fold sample expansion, enabling the visualization of different post-entry stages of the HIV-1 life cycle, focusing on nuclear events. Our findings demonstrate that U-ExM provides robust sample expansion and preservation across different cell types, including cell-culture-adapted and primary CD4+ T-cells as well as monocyte-derived macrophages, which are known HIV-1 reservoirs. Notably, cellular targets such as nuclear bodies and the chromatin landscape remain well preserved after expansion, allowing for detailed investigation of HIV-1-cell interactions at high resolution. Our data indicate that morphologically distinct HIV-1 capsid assemblies can be differentiated within the nuclei of infected cells and that U-ExM enables detection of targets that are masked in commonly used immunofluorescence protocols. In conclusion, we advocate for U-ExM as a valuable new tool for studying virus-host interactions with enhanced spatial resolution.

Identifiants

pubmed: 39459943
pii: v16101610
doi: 10.3390/v16101610
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : 240245660
Organisme : German Center for Infection Research
ID : TTU 04.710
Organisme : Deutsche Forschungsgemeinschaft
ID : KR 906/7-1

Auteurs

Annett Petrich (A)

Department of Infectious Diseases, Virology, Heidelberg University, 69120 Heidelberg, Germany.

Gyu Min Hwang (GM)

Department of Infectious Diseases, Virology, Heidelberg University, 69120 Heidelberg, Germany.

Laetitia La Rocca (L)

Department of Infectious Diseases, Virology, Heidelberg University, 69120 Heidelberg, Germany.

Mariam Hassan (M)

Department of Infectious Diseases, Virology, Heidelberg University, 69120 Heidelberg, Germany.

Maria Anders-Össwein (M)

Department of Infectious Diseases, Virology, Heidelberg University, 69120 Heidelberg, Germany.

Vera Sonntag-Buck (V)

Department of Infectious Diseases, Virology, Heidelberg University, 69120 Heidelberg, Germany.

Anke-Mareil Heuser (AM)

Department of Infectious Diseases, Virology, Heidelberg University, 69120 Heidelberg, Germany.

Vibor Laketa (V)

Department of Infectious Diseases, Virology, Heidelberg University, 69120 Heidelberg, Germany.
German Center for Infection Research (DZIF), Partner Site Heidelberg, 69120 Heidelberg, Germany.

Barbara Müller (B)

Department of Infectious Diseases, Virology, Heidelberg University, 69120 Heidelberg, Germany.

Hans-Georg Kräusslich (HG)

Department of Infectious Diseases, Virology, Heidelberg University, 69120 Heidelberg, Germany.
German Center for Infection Research (DZIF), Partner Site Heidelberg, 69120 Heidelberg, Germany.

Severina Klaus (S)

Department of Infectious Diseases, Virology, Heidelberg University, 69120 Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH